To evaluate the effect of TACC3 on bladder cancer (BC) growth in vivo, we established a xenograft model by subcutaneously injecting TACC3-knockdown 5637 cells and control cells into mice. This evidence concerns the gene TACC3 and urinary bladder cancer.